PharmaSourcesJuly 13, 2021
Tag: Eplerenone , API Powder , aldosterone
Eplerenone is a selective aldosterone antagonist, a diuretic that is used to treat patients with high blood pressure and heart failure. The brand name for eplerenone is Inspra.
Eplerenone is available in a couple of different forms and specifications including eplerenone API powder and eplerenone tablets.
Raw material of eplerenone API powder (CAS 107724-20-9) is in the form of a white to off-white crystalline powder. The specification from Chinese manufacturers Zhejiang Shenzhou Pharmaceutical Co., Ltd., Zhejiang Chempharm Industry & Trading Co., Ltd., Aurisco Pharmaceutical Co., Ltd., Zhejiang Pure Pharmaceutical Co., Ltd., and Biosyn Healthy Pharma Co., Ltd is 99% min.
Eplerenone is available in generic and brand 25 mg and 50 mg tablets.
Eplerenone and spironolactone are both aldosterone antagonist diuretics used to treat heart failure and high blood pressure. However, eplerenone is selective whereas spironolactone is nonselective. Spironolactone can also be used to treat hyperaldosteronism. Eplerenone is available in 25 mg and 50 mg tablets, and spironolactone is available in 25, 50, and 100 mg tablets.
Eplerenone exhibits its mechanism of action by binding to the mineralcorticoid receptor, interfering with the binding of aldosterone, resulting in decreased sodium resorption and increased urine output. This causes a reduction in edema and blood pressure (PubChem Compound Summary for CID 443872, Eplerenone).
In accordance with Good Manufacturing Practice, eplerenone is made from the raw material,11-alpha-Hydroxycarvenone, to form the intermediate, 11-alpha-Hydroxy canrenone methacrylate. Impurities are then removed until eplerenone API powder reaches 99% min purity specification.
Eplerenone is a diuretic used to heart failure and high blood pressure.
For adults with high blood pressure, the initial dose is 50 mg by mouth once daily and may be increased to 50 mg by mouth every 12 hours. For patients with heart failure, the initial dose is 25 mg by mouth once daily and may titrate to a maximum dose of 50 mg once daily as tolerated.
Side effects may include hyperkalemia, cough, dizziness, fatigue, abdominal pain, albuminuria, hypercholesterolemia, and hypertriglyceridemia.
Below are some manufacturers who are professional in making API active product ingredient.
Chinese manufacturers, Zhejiang Shenzhou Pharmaceutical Co., Ltd., Zhejiang Chempharm Industry & Trading Co., Ltd., Aurisco Pharmaceutical Co., Ltd., Zhejiang Pure Pharmaceutical Co., Ltd., and Biosyn Healthy Pharma Co., Ltd manufacture raw material of eplerenone API powder 99% in bulk. If you need a price quote, certificate of analysis (COA), or a detailed specification sheet, please visit these suppliers of eplerenone API on www.pharmasources.com.
Established in 1988, Zhejiang Shenzhou Pharmaceutical Co., Ltd. is an advanced company specializing in research, manufacturing, and sales of steroid medication APIs and intermediates. They are known for their “provincial high-tech research and development center, the provincial technical center, the provincial enterprise research institute, and the provincial foreign trade public service platform” (PharmaSources). In addition, they have developed a joint laboratory with the Chinese Academy of Sciences.
For more information about Zhejiang Shenzhou Pharmaceutical Co., Ltd., visit www.pharmasources.com.
Established in 1996, Zhejiang Chempharm Industry & Trading Co., Ltd. specializes in the international industry and generic market. They provide development of new intermediates, factory auditing/GMP validation, quality control and assurance, DMF documents preparation, logistics, financial support, and after-shipment service.
For more information about Zhejiang Chempharm Industry & Trading Co., Ltd., visit www.pharmasources.com.
Established in 2002, Aurisco Pharmaceutical Co., Ltd. is innovated, committed to providing services to pharmaceutical companies worldwide. They are continuously broadening their scientific and technology base while focusing on state-of-the-art plants and equipment that ensure high-quality production in a safe environment.
For more information about Aurisco Pharmaceutical Co., Ltd., visit www.pharmasources.com.
Established in 2009, Zhejiang Pure Pharmaceutical Co., Ltd. specializes in the manufacturing of steroid hormones API. They are committed to the research, manufacturing, and innovation of steroid hormone products as they are one of the leading manufacturers of steroid hormones API. They focus on customers first, always looking for ways to improve their company and management to provide better services.
For more information about Zhejiang Pure Pharmaceutical Co., Ltd., visit www.pharmasources.com.
Established in 2003, Biosyn Health Pharma Co., Ltd. is technologically advanced, specializing in the manufacturing of pharmaceutical APIs and intermediates. They focus on providing high-quality products with professional service.
For more information about Biosyn Healthy Pharma Co., Ltd., visit www.pharmasources.com.
Visit pharmasources.com to find the highest quality products manufactured by the most experienced suppliers. PharmaSources has expanded their services to more than 900,000 active members across 211 countries and regions. They display more than 1,600,000 products in 30 major categories that span the entire pharma supply chain. Their mission is “to connect global buyers with quality suppliers and facilitate easy trade of the pharmaceutical industry” (PharmaSources).
According to HDIN Research, the market size of eplerenone is expected to grow at a CAGR of 2.5% to reach 23.0 mt through 2024.
Eplerenone is widely known to be very effective in reducing mortality from heart failure. However, studies have shown that eplerenone is no more effective in reducing clinical events than cheaper aldosterone antagonists (Saurav, et al.). It should cost as much as the other aldosterone antagonists.
Eplerenone is a selective aldosterone receptor antagonist whereas spironolactone is nonselective.
Amiloride works by interfering with salt and water movement across kidney cells whereas eplerenone works by blocking aldosterone.
1. Aldactone VS. Inspra (eplerenone). RxList. https://www.rxlist.com/aldactone_vs_inspra_
eplerenone/drugs-condition.htm. Accessed June 17, 2021.
2. Barnes BJ, Howard PA. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure [published correction appears in Ann Pharmacother. 2005 May;39(5):978]. Ann Pharmacother. 2005;39(1):68-76. https://pubmed.ncbi.nlm.nih.gov/15590870/
3. Chatterjee S, Moeller C, Shah N, et al. Eplerenone is not superior to older and less expensive aldosterone antagonists. Am J Med. 2012;125(8):817-825. https://pubmed.ncbi.nlm.nih.gov/22840667/
4. Company Profile of Aurisco Pharmaceutical Co., Ltd. PharmaSources. https://www.pharmasources.com/company-profile/aurisco-pharmaceutical-co-ltd-userId-233.html. Accessed June 17, 2021.
5. Company Profile of Biosyn Healthy Pharma Co., Ltd. PharmaSources. https://www.pharmasources.com/company-profile/biosyn-healthy-pharma-co-ltd-userId-970.html. Accessed June 17, 2021.
6. Company Profile of Zhejiang Chempharm Industry & Trading Co., Ltd. PharmaSources. https://www.pharmasources.com/company-profile/zhejiang-chempharm-industry-trading-co-l-userId-68034.html. Accessed June 17, 2021.
7. Company Profile of Zhejiang Pure Pharmaceutical Co., Ltd. PharmaSources. https://www.pharmasources.com/company-profile/zhejiang-pure-pharmaceutical-co-ltd-userId-428.html. Accessed June 17, 2021.
8. Company Profile of Zhejiang Shenzhou Pharmaceutical Co., Ltd. PharmaSources. https://www.pharmasources.com/company-profile/zhejiang-shenzhou-pharmaceutical-co-ltd-userId-384.html. Accessed June 17, 2021.
9. Eplerenone. DrugBank. https://go.drugbank.com/drugs/DB00700. Accessed June 17, 2021.
10. Eplerenone. GoodRx. https://www.goodrx.com/eplerenone. Accessed June 17, 2021.
11. Eplerenone API Market Size will reach to 23.0 mt in 2024. HDIN Research. https://www.hdinresearch.com/news/63. December 16, 2019. Accessed June 17, 2021.
12. Eplerenone (Rx). MedScape. https://reference.medscape.com/drug/inspra-eplerenone-342397#4. Accessed June 17, 2021.
13. Knott, Laurence. Potassium-sparing Diuretics. Patient. https://patient.info/digestive-health/dietary-potassium/potassium-sparing-diuretics. Edited May 26, 2020. Accessed June 17, 2021.
14. National Center for Biotechnology Information. PubChem Compound Summary for CID 443872, Eplerenone. https://pubchem.ncbi.nlm.nih.gov/compound/Eplerenone. Accessed June 17, 2021.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: